Ultrasound tissue characterization detects preclinical myocardial structural changes in children affected by Duchenne muscular dystrophy

Journal of the American College of Cardiology

Volumn 42, Issue 2, 2003, Pages 309-316

  Giglio, Vincenzo ^a,b   Pasceri, Vincenzo ^c   Messano, Loredana ^a,d   Mangiola, Fortunato ^a   Pasquini, Luciano ^e   Dello Russo, Antonio ^a,d   Damiani, Antonello ^a   Mirabella, Massimiliano ^a,d   Galluzzi, Giuliana ^a,d   Tonali, Pietro ^d,f   Ricci, Enzo ^a,d  

^a Center for Neuromuscular Diseases   (Italy)

^b Division of Cardiology   (Italy)

^c SAN FILIPPO NERI HOSPITAL   (Italy)

^d CATHOLIC UNIVERSITY   (Italy)

^e BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^f CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROPHIN;

ARTICLE; CARDIOMYOPATHY; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DUCHENNE MUSCULAR DYSTROPHY; EARLY DIAGNOSIS; ECHOGRAPHY; FEMALE; HEART FUNCTION; HEART MUSCLE; HUMAN; MALE; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; STRUCTURE ANALYSIS; SYSTOLE; ULTRASONIC TISSUE CHARACTERIZATION;

EID: 0038639602     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(03)00581-3     Document Type: Article

References (33)

1. Rybakova IN, Patel JR, Davies KE, et al. The dystrophin complex forms a mechanically strong link between the sarcolemma and costameric actin. J Cell Biol 2000;150:1209-14.
2. Grady RM, Grange RW, Lau KS, et al. Role for alpha-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies. Nat Cell Biol 1999;1:215-20.
3. Hudgson P, Pearse WG, Walton JN. Preclinical muscular dystrophy: histopathological changes observed in muscle biopsy. Brain 1967;90: 565-6.
4. Mahoney MJ, Haseltine FT, Hobbins JC, et al. Prenatal diagnosis of Duchenne's muscular dystrophy. N Engl J Med 1977;297:968-73.
5. Muntoni F, Wilson L, Marrosu G, et al. A mutation in the dystrophin gene selectively affecting dystrophin expression in the heart. J Clin Invest 1996;96:693-9.
6. Frankel KA, Rosser RJ. The pathology of the heart in progressive muscular dystrophy: epimyocardial fibrosis. Hum Pathol 1976;7:375-86.
7. Sanjal SK, Johnson WW, Thapar MK, et al. An ultrastructural basis for electrocardiographic alterations associated with Duchenne's progressive muscular dystrophy. Circulation 1978;57:1122-9.
8. Nigro G, Politano L, Nigro V, et al. Mutation of dystrophin gene and cardiomyopathy. Neuromusc Disord 1994;4:371-9.
9. Mori K, Manabe T, Nii M, et al. Myocardial integrated ultrasound backscatter in patients with Duchenne's progressive muscular dystrophy. Heart 2001;86:341-2.
10. Colan SD, Borow KM, Neumann A. Left ventricular end-systolic wall stress-velocity of fiber shortening relation: a load-independent index of myocardial contractility. J Am Coll Cardiol 1984;4:715-24.
11. Naito J, Masuyama T, Mano T, et al. Validation of transthoracic myocardial ultrasonic tissue characterization: comparison of transthoracic and open-chest measurements of integrated backscatter. Ultrasound Med Biol 1995;21:33-49.
12. Stuhlmuller JE, Skorton DJ, Burns TL, et al. Reproducibility of quantitative backscatter echocardiographic imaging in normal subjects. Am J Cardiol 1992;69:542-6.
13. Recchia D, Miller JG, Wickline A. Quantification of ultrasonic anisotropy in normal myocardium with lateral gain compensation of two-dimensional integrated backscatter images. Ultrasound Med Biol 1993;19:497-505.
14. Holland MR, Wilkenshoff UM, Finch-Johnston AE, et al. Effects of myocardial fiber orientation in echocardiography: quantitative measurements and computer simulation of the regional dependence of backscattered ultrasound in the parasternal short-axis view. J Am Soc Echocardiogr 1998;11:929-37.
15. Shiller N, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989;2:358-67.
16. Mohr GA, Vered Z, Barzilai B, et al. Automated determination of the magnitude and time delay ("phase") of the cardiac cycle dependent variation of myocardial ultrasonic integrated backscatter. Ultrasound Imaging 1989;11:245-9.
17. Finch-Johnston AE, Gussak HM, Mobley J, et al. Cyclic variation of integrated backscatter: dependence of time delay on the echocardiographic views used and the myocardial segment analized. J Am Soc Echocardiogr 2000;3:9-17.
18. Perez JE, Barzilai B, Madaras EI, et al. Applicability of ultrasonic tissue characterization for longitudinal assessment and differentiation of calcification and fibrosis in cardiomyophathy. J Am Coll Cardiol 1984;4:88-95.
19. Hoyt RH, Collins SM, Skorton DJ, et al. Assessment of fibrosis in infarcted human hearts by analysis of ultrasonic backscatter. Circulation 1985;71:740-4.
20. Hoyt RH, Skorton DJ, Collins SM, et al. Ultrasonic backscatter and collagen in normal ventricular myocardium. Circulation 1984;69:775-82.
21. Naito J, Masuyama T, Mano T, et al. Ultrasonic myocardial tissue characterization in patients with dilated cardiomyopathy: value in noninvasive assessment of myocardial fibrosis. Am Heart J 1996;131: 115-21.
22. Masuyama T, Nellessen U, Schnittger I, et al. Ultrasonic tissue characterization with a real-time integrated backscatter imaging system in normal and aging human hearts. J Am Coll Cardiol 1989;14: 1702-8.
23. Vered Z, Barzilai B, Mohr GA, et al. Quantitative ultrasonic tissue characterization with real-time integrated backscatter imaging in normal human subjects and in patients with dilated cardiomyopathy. Circulation 1987;76:1067-73.
24. Milunski MR, Mohr GA, Perez JE, et al. Ultrasonic tissue characterization with integrated backscatter: acute myocardial ischemia, reperfusion and stunned myocardium in patients. Circulation 1989;80:491-503.
25. O'Brien PD, O'Brien WD, Rhyne TL, et al. Relation of ultrasonic backscatter and acoustic propagation properties to myofibrillar lenght and myocardial thickness. Circulation 1995;91:171-5.
26. Sagar KB, Pelc LE, Rhyne TL, et al. Influence of heart rate, preload, afterload, and inotropic state on myocardial ultrasonic backscatter. Circulation 1988;83:762-9.
27. Wickline SA, Thomas LJ, Miller JG, et al. The dependence of myocardial ultrasonic integrated backscatter on contractile performance. Circulation 1985;72:183-92.
28. Wickline SA, Thomas LJ, Miller JG, et al. A relationship between ultrasonic integrated backscatter and myocardial contractile function. J Clin Invest 1985;76:2151-60.
29. Quinlivan RM, Lewis P, Marsden P, et al. Cardiac function metabolism and perfusion in Duchenne and Becker muscular dystrophy. Neuromusc Disord 1996;6:237-46.
30. Chen YW, Zhao P, Borup R, et al. Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology. J Cell Biol 2000;151:1321-36.
31. Goens MB, Karr SS, Martin GR. Cyclic variation of integrated ultrasound backscatter: normal and abnormal myocardial patterns in children. J Am Soc Echocardiogr 1996;9:616-21.
32. Chamberlain JS. Muscular dystrophy meets the gene chip: new insights into disease pathogenesis. J Cell Biol 2000;151:F43-6.
33. Suwa M, Ito T, Kobashi A, et al. Myocardial integrated ultrasonic backscatter in patients with dilated cardiomyopathy: prediction of response to beta-blocker therapy. Am Heart J 2000;139:905-12.